purduepharma.com Open in urlscan Pro
44.193.53.182  Public Scan

Form analysis
3 forms found in the DOM

GET https://purduepharma.com/

<form role="search" method="get" class="et-search-form" action="https://purduepharma.com/">
  <input type="search" class="et-search-field" placeholder="Search …" value="" name="s" title="Search for:">
</form>

POST

<form style="margin: -30px 3px 7px -16px!important; text-align: right;" id="wptp-form" method="post"><input class="termsagree" name="wptp_agree" type="submit" value="X"></form>

POST

<form id="wptp-form" method="post">
  <div class="tthebutton">
    <input class="termsagree" name="wptp_agree" type="submit" value="I Agree">
    <input class="termsdecline" type="button" onclick="window.location.replace('https://www.google.com/')" value="I Do Not Agree">
  </div>
</form>

Text Content

 * Restructure
 * About Purdue
   * Ethics and Compliance
   * Locations & Operations
   * Public Policies
 * News & Media
   * Perspectives
   * STORIES
   * Media Contact
 * Careers at Purdue
   * What We Offer You
   * How to Apply
 * Contact Us
 * 
 * 

 * Healthcare Professionals
   * Purdue Products
   * Patient Savings
   * Ask Purdue Medical
   * Responsible Use of Opioids
   * Clinical Trials
   * Investigator-Initiated Research
 * Patients & Caregivers
   * Medicines From Purdue
   * Cost Savings
   * Ask Purdue Medical
   * Responsible Use of Opioids
   * Expanded Access Program
   * Supporting Responsible Prescription Stimulant Use
 * Addressing the Crisis
   * Public Health Initiatives
   * Public Policies
   * Perspectives
 * Partnering
 * Corporate Social Responsibility
   * Grants & Giving
   * Case Studies


Select Page
 * Healthcare Professionals
   * Purdue Products
   * Patient Savings
   * Ask Purdue Medical
   * Responsible Use of Opioids
   * Clinical Trials
   * Investigator-Initiated Research
 * Patients & Caregivers
   * Medicines From Purdue
   * Cost Savings
   * Ask Purdue Medical
   * Responsible Use of Opioids
   * Expanded Access Program
   * Supporting Responsible Prescription Stimulant Use
 * Addressing the Crisis
   * Public Health Initiatives
   * Public Policies
   * Perspectives
 * Partnering
 * Corporate Social Responsibility
   * Grants & Giving
   * Case Studies
 * Restructure
 * About Purdue
   * Ethics and Compliance
   * Locations & Operations
   * Public Policies
 * News & Media
   * Perspectives
   * STORIES
   * Media Contact
 * Careers at Purdue
   * What We Offer You
   * How to Apply
 * Contact Us
 * 
 * 




RESTRUCTURE INFORMATION

Purdue’s confirmed Plan of Reorganization (“Plan”) was vacated on appeal by the
United States District Court for the Southern District of New York. Purdue is
appealing the ruling while simultaneously continuing its efforts to forge yet
further consensus around a Plan that will deliver billions of dollars to the
American people for opioid abatement. The District Court decision does not
affect Purdue’s operational stability or its ability to produce its many
medications safely and effectively. We continue to operate fully, honoring our
existing relationships and meeting our obligations to our partners, customers,
and consumers. The company continues serving patients and consumers who rely on
its medicines and products, pursuing its pipeline, and introducing medicines
that will help save and improve lives.

Click here to learn more


PATIENT-FIRST APPROACH IN DEVELOPING MEDICINES

LEARN MORE


HERE TO ANSWER YOUR QUESTIONS

LEARN MORE


THE THINGS WE CARE ABOUT

LEARN MORE


JOIN OUR TEAM

LEARN MORE


COMMITTED TO SUPPORTING COMPASSIONATE CARE

LEARN MORE
12345


RECENT NEWS


PURDUE PHARMA L.P. TO PROVIDE FUNDING OPPORTUNITIES FOR INVESTIGATOR-INITIATED
RESEARCH TO EXAMINE OPIOID OVERDOSE REVERSAL USING NALMEFENE HCL INJECTION

by Ahmed Ijaz | March 28, 2023 | News | 0 Comments

Purdue Pharma L.P. to Provide Funding Opportunities for Investigator-Initiated
Research to Examine Opioid Overdose Reversal Using Nalmefene HCl Injection
Stamford, Conn., March 28, 2023 – Purdue…


HARM REDUCTION THERAPEUTICS TO RECEIVE ADDITIONAL FUNDING FOR ITS LOW-COST
OVER-THE-COUNTER OPIOID OVERDOSE REVERSAL MEDICATION FROM PURDUE PHARMA

by Ahmed Ijaz | March 21, 2023 | News | 0 Comments

Harm Reduction Therapeutics to Receive Additional Funding for its Low-Cost
Over-the-Counter Opioid Overdose Reversal Medication from Purdue Pharma $9
million in funding for commercial readiness…


FDA GRANTS PRIORITY REVIEW FOR NALMEFENE PREFILLED SYRINGE FOR THE TREATMENT OF
KNOWN OR SUSPECTED OPIOID OVERDOS

by Ahmed Ijaz | January 18, 2023 | News | 0 Comments

Stamford, Conn., Jan, 18, 2023 – Purdue Pharma L.P. (“Purdue”) announced that
FDA has accepted and granted priority review to the company’s Abbreviated New
Drug Application (ANDA) for Nalmefene…
PreviousNext
123
MORE NEWS


OPINION – STEVE MILLER: PURDUE PHARMA CHAIR ON ‘TRAGIC’ SETTLEMENT DECISION;
STAMFORD ADVOCATE

December 31, 2021

The U.S. District Court’s decision vacating the settlement reached in Purdue’s
bankruptcy proceedings threatens not only to upend U.S. bankruptcy law but also
to significantly delay —and possibly prevent entirely — billions of dollars from
being used to address the opioid crisis. It is a regrettable and tragic outcome
that could have been, and hopefully still can be, avoided.

Read More Here



NIKKI’S HOUSE: SUPPORTING WOMEN IN RECOVERY

In 2017, Nicole Wesley, MD, MBA, MHA, lost her father to congestive heart
failure. When she inherited his home in Warren, Ohio, Nicole knew she could do
something special with it. Five months later, Nikki’s House – a recovery home
for women healing from substance use disorder – opened its doors to the first
two women. Five years later, Nikki’s House has given approximately 250 women the
opportunity to live sober lives.

Read More


MOVE TOGETHER, HEAL TOGETHER

Ethan Hershman has been in recovery from substance use disorder for 28 years.
While he’s never once relapsed, he’s seen his fair share of people who haven’t
been as fortunate and, in many tragic cases, have lost their lives. He finally
asked himself, “why?”

Read More


RENEWAL HOUSE: KEEPING FAMILIES TOGETHER AND CREATING BRIGHT FUTURES FOR WOMEN
AND CHILDREN

Mothers seeking treatment for substance use disorder often must choose between
taking care of their children and taking care of themselves. Renewal House is
offering mothers in Middle Tennessee a different option – one where they don’t
have to choose.

Read More
PreviousNext
123

TERMS & CONDITIONS

LOCATION & OPERATIONS

CONTACT US

REPORT AN ADVERSE EVENT

ASK PURDUE MEDICAL

DO NOT SELL MY INFORMATION

ETHICS & COMPLIANCE

SITE MAP

PATIENT SAVINGS PROGRAM

PURDUE PRIVACY POLICY/CCPA REQUESTS

Purdue, as used in this site, refers to Purdue Pharma L.P. and its subsidiaries,
which include Avrio Health L.P., Imbrium Therapeutics L.P., Adlon Therapeutics
L.P., Greenfield BioVentures L.P., Rhodes Pharmaceuticals L.P., and Purdue
Pharmaceuticals L.P.
When you access any of our websites, related other parties’ websites, mobile
applications, or any electronic service, we may use cookies and other
technologies to automatically collect information regarding you and your device
to assess user activity and preferences. We may also use third-party analytic
tools to assist with the collection of information including, but not limited
to, Google Analytics. By using this site, you agree to our use of these
technologies in accordance with our Privacy Policy.Ok


PRIVACY POLICY UPDATES


Please read carefully the Purdue Pharma L.P. Privacy Policy (the “Privacy
Policy”), which is part of the Purdue Pharma L.P. Terms and Conditions, before
you access, download, or otherwise use any of our websites, related other
parties’ websites, mobile applications, or any electronic service (collectively,
the “Service”). This Privacy Policy describes the information collected through
Your use of the Service, how we use it, how we share it, how we protect it, and
the choices You can make about Your information.